BiotechTube
Home/Aldeyra Therapeutics/Ben H. McGraw III
BH

Ben H. McGraw III

Chief Commercial Officer

Aldeyra Therapeutics

Therapeutic Areas

OphthalmologyImmunology

Aldeyra Therapeutics Pipeline

DrugIndicationPhase
ReproxalapDry Eye DiseaseNDA Submitted
ADX-2191Primary Vitreoretinal LymphomaPhase 3
ADX-629Systemic Immune-Mediated DiseasesPhase 2a

Leadership Team at Aldeyra Therapeutics

TC
Todd C. Brady
President, CEO & Chairman
DJ
David J. Clark
Chief Medical Officer
JR
Joshua Reed
Chief Financial Officer & Treasurer
SG
Stephen G. Machatha
Chief Development Officer
View full Aldeyra Therapeutics profile